glp-1 combination therapy Influence of with SGLT2 inhibitors and receptor agonists on the management of blood pressure in Japanese patients with diabetes fig3.gif

Unfortunately, though, our bodies must contend with an ever-growing onslaught of free radicals that hitchhike into the body on the backs of chemicals in the air, water supply, and food chain

While these synthetic GLP-1 agonists have demonstrated remarkable efficacy in clinical trials, they are associated with a range of side effects, including common gastrointestinal issues such as nausea, vomiting, diarrhea, and constipation, which are often dose-dependent (Kommu S et al., 2025

It also says patients on insulin or certain diabetes medications may need closer monitoring when GLP-1 treatment is started

Who wants to fund my study ;) Three groups start at the same place